Nioxin is owned by KKR (the United States, NYSE: KKR) through its subsidiary Wella Company, which acquired the brand on 1 December 2020 from Coty.[1][2] Nioxin was founded in 1987 in the United States and was independent until 2020.
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Nioxin makes scalp and hair treatments for thinning hair, sold through salons and positioned around scalp health rather than cosmetic thickening. It sits within Wella Company alongside the other professional brands. Wella Company was carved out of Coty in 2020 when KKR acquired a majority of the professional beauty business.
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full KKR ownership tree →
Coty sold a controlling sixty per cent stake in its professional beauty and retail hair business to KKR, valuing it at about $4.3 billion. The carve-out created Wella Company as a standalone business, which is why salon brands and Coty fragrances now sit under different owners.
No tagged news items yet. Headlines are added nightly from public feeds; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
The parent company of Nioxin is KKR, a private-equity firm headquartered in the United States. Nioxin sits under KKR's subsidiary Wella Company.
Yes. Nioxin originated in the United States in 1987 and its owner, KKR, is also headquartered in the United States.
KKR completed its acquisition of Nioxin on 1 December 2020, after announcing the deal on 1 June 2020.
Nioxin was an independent company from its founding in 1987 until KKR acquired it in 2020.
Yes. As of 8 September 2026, Nioxin is still owned by KKR. The ownership record was last checked against primary sources on that date.
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.